Literature DB >> 12356640

Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.

Katrin Schäfer1, Stavros Konstantinides, Carsten Riedel, Therese Thinnes, Katja Müller, Claudia Dellas, Gerd Hasenfuss, David J Loskutoff.   

Abstract

BACKGROUND: Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) are thought to play critical roles in vascular remodeling after injury, with tPA mediating intravascular clot lysis and uPA modulating cell migration within the vessel wall. In human vascular disease, however, thrombus organization and neointimal formation are closely interrelated processes. This study examines the differential roles of tPA and uPA in these processes in mice. METHODS AND
RESULTS: Carotid artery injury and thrombosis were induced in wild-type (WT), uPA-deficient (uPA(-/-)), and tPA-deficient (tPA(-/-)) mice with the use of ferric chloride. The expression of uPA and tPA was significantly upregulated in the vessel wall of WT mice 1 week after injury, and compared with WT mice, uPA(-/-) and tPA(-/-) mice had lower carotid patency rates after injury. At 3 weeks, only 55% of uPA(-/-) mouse vessels were patent compared with 81% in tPA(-/-) mice and 100% in WT mice (P=0.014). Morphometric analysis of injured arterial segments revealed severe luminal stenosis (62+/-28%) in uPA(-/-) mice compared with their tPA(-/-) (16+/-12%) and WT (6.3+/-3.6%, P<0.001) counterparts. Moreover, although the vascular walls of WT mice and, particularly, tPA(-/-) mice developed a cell-rich multilayered neointima and media, the lumen of uPA(-/-) vessels remained obstructed with acellular unorganized thrombotic material, and their medial areas did not expand.
CONCLUSIONS: These results indicate that the roles of uPA and tPA in the arterial response to injury are different and more complex than previously assumed and emphasize the critical role of thrombus organization and resolution in neointimal formation and vascular pathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356640     DOI: 10.1161/01.cir.0000031162.80988.2b

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.

Authors:  Antje Butschkau; Nana-Maria Wagner; Laura Bierhansl; Berit Genz; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Experimental study of tissue-type plasminogen activator gene to prevent vein grafts stenosis.

Authors:  Xionggang Jiang; Xiaobin Liu; Kailun Zhang; Jiahong Xia; Daokang Xiang; Long Wu; Cheng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

3.  Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.

Authors:  Thomas Bonnard; Christoph E Hagemeyer
Journal:  J Vis Exp       Date:  2015-06-29       Impact factor: 1.355

Review 4.  Dysfunctional platelet membrane receptors: from humans to mice.

Authors:  Jerry Ware
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

5.  Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

Authors:  Jianbo Wu; Lin Peng; Grainne A McMahon; Daniel A Lawrence; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-02       Impact factor: 8.311

6.  Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2014-07-02       Impact factor: 2.192

7.  Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.

Authors:  Qi Ling; Andrew T Jacovina; Arunkumar Deora; Maria Febbraio; Ronit Simantov; Roy L Silverstein; Barbara Hempstead; Willie H Mark; Katherine A Hajjar
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

8.  The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice.

Authors:  Magdalena L Bochenek; Tobias Bauer; Rajinikanth Gogiraju; Yona Nadir; Amrit Mann; Tanja Schönfelder; Leonie Hünig; Benjamin Brenner; Thomas Münzel; Philip Wenzel; Stavros Konstantinides; Katrin Schäfer
Journal:  Blood Adv       Date:  2018-06-12

9.  The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.

Authors:  Joe F Baldwin; Vikram Sood; Megan A Elfline; Cathy E Luke; Nicholas A Dewyer; Jose A Diaz; Dan D Myers; Thomas Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2012-07-15       Impact factor: 4.268

10.  ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery.

Authors:  Tian-xiang Zhu; Bin Lan; Ling-ying Meng; Yan-long Yang; Rui-xiong Li; En-min Li; Shao-yi Zheng; Li-yan Xu
Journal:  J Cardiothorac Surg       Date:  2013-06-18       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.